Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovis Pharma is a leading pharmaceutical company based in Greece, established in 2017 through the strategic merger of the pharmaceutical divisions of several prominent Greek entities. The company focuses on the commercialization of both innovative and generic pharmaceutical products across a wide range of therapeutic areas, including cardiology, central nervous system (CNS), respiratory, and oncology. Innovis Pharma operates through a robust network of international partnerships, licensing products from global pharmaceutical leaders to bring advanced treatments to the Greek market. As a member of the Vianex Group, the largest pharmaceutical group in Greece, Innovis leverages extensive manufacturing and distribution capabilities to maintain a significant market presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovis Investment Partners.